Evaluation of the Vitek system to accurately test the susceptibility of Pseudomonas aeruginosa clinical isolates against cefepime (Q77583674)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9823533%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

title

Evaluation of the Vitek system to accurately test the susceptibility of Pseudomonas aeruginosa clinical isolates against cefepime (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9823533%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

main subject

Pseudomonas aeruginosa

object named as

Pseudomonas aeruginosa

1 reference

1

R N Jones

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9823533%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

4

M A Pfaller

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9823533%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

author name string

D J Biedenbach

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9823533%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

S A Marshall

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9823533%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

G V Doern

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9823533%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

publication date

1 October 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9823533%20AND%20SRC:MED&resulttype=core&format=json

Diagnostic Microbiology and Infectious Disease

6 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9823533%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9823533%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9823533%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

page(s)

107-110

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9823533%20AND%20SRC:MED&resulttype=core&format=json

Interpretive errors using an automated system for the susceptibility testing of imipenem and aztreonam.

6 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900051-0

7 January 2021

Multicenter evaluation of antimicrobial resistance to six broad-spectrum beta-lactams in Colombia using the Etest method. The Colombian Antimicrobial Resistance Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900051-0

7 January 2021

Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900051-0

7 January 2021

Microbiologic and pharmacodynamic principals applied to the antimicrobial susceptibility testing of ampicillin/sulbactam: analysis of the correlations between in vitro test results and clinical response

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900051-0

7 January 2021

Critical evaluation of the Vitek GNS F6 card results compared to standardized, reference susceptibility test methods

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900051-0

7 January 2021

Antimicrobial activity and spectrum investigation of eight broad-spectrum beta-lactam drugs: a 1997 surveillance trial in 102 medical centers in the United States. Cefepime Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900051-0

7 January 2021

Antimicrobial susceptibility testing: general principles and contemporary practices

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900051-0

7 January 2021

Susceptibility of bacterial isolates to beta-lactam antibiotics from U.S. clinical trials over a 5-year period

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900051-0

7 January 2021

Serious interpretive error among three commercial systems for susceptibility testing of aztreonam. Aztreonam Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900051-0

7 January 2021

Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900051-0

7 January 2021

Randomized comparison of cefepime and ceftazidime for treatment of hospitalized patients with gram-negative bacteremia.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900051-0

7 January 2021

Multicenter evaluation of the antimicrobial activity for six broad-spectrum beta-lactams in Venezuela using the Etest method. The Venezuelan Antimicrobial Resistance Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900051-0

7 January 2021

10.1016/S0732-8893(98)00051-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9823533%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference